Library

Alias: Cagri

Cagrilintide is a long-acting amylin analogue developed for the study of appetite regulation, energy balance, and body-weight management. It is designed to mimic the actions of amylin, a naturally occurring hormone released alongside insulin by pancreatic beta cells after meals. Research suggests that amylin signaling plays an important role in promoting satiety, slowing gastric emptying, and regulating food intake. Due to these effects, Cagrilintide has become a subject of significant interest in obesity and metabolic-health research. It is frequently studied both as a standalone compound and in combination with GLP-1 receptor agonists.

Retatrutide is an investigational triple-hormone receptor agonist that activates GLP-1, GIP, and glucagon receptors. It is currently being studied for obesity, weight management, and metabolic health. By targeting three metabolic pathways simultaneously, Retatrutide has demonstrated significant weight-loss potential in clinical research and represents a next-generation approach to metabolic therapy.

Semaglutide is a GLP-1 receptor agonist widely studied for weight management, obesity, glucose regulation, and metabolic health. It works by mimicking the naturally occurring hormone glucagon-like peptide-1 (GLP-1), which plays a key role in appetite control, insulin secretion, and blood glucose regulation. Semaglutide has become one of the most extensively researched peptides in the weight-management field and has demonstrated significant effects on body weight and metabolic outcomes.

Alias: ACTH(4-10) Analogue

Semax is a synthetic peptide derived from a fragment of adrenocorticotropic hormone (ACTH). Originally developed in Russia, it has been extensively studied for its potential effects on cognitive performance, neuroprotection, learning, memory, and neurological recovery. Unlike traditional stimulants, Semax does not appear to exert its effects through direct stimulation of the central nervous system. Instead, research suggests it may influence neurotrophic factors, neurotransmitter systems, and brain signaling pathways involved in cognition and resilience. Due to these properties, Semax has become a popular subject of investigation within the fields of neuroscience, cognitive enhancement, and neuroprotection.

Alias: TA1

Thymosin Alpha-1 (TA1) is a naturally occurring peptide originally isolated from the thymus gland. It plays an important role in immune system regulation and has been extensively studied for its effects on T-cell function, immune signaling, and host defense mechanisms. Due to its involvement in immune modulation, TA1 has attracted interest in research relating to infection, inflammation, immune resilience, and healthy aging.

Tirzepatide is a dual GIP and GLP-1 receptor agonist developed for the treatment of metabolic disorders. It is widely studied for weight management, obesity, and glucose regulation due to its ability to influence appetite, satiety, insulin secretion, and energy intake. By targeting both GIP and GLP-1 receptors, Tirzepatide represents a significant advancement beyond traditional GLP-1-only therapies.